| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 276 | 22.832 | 1.890 |
| Total Income - EUR | - | - | - | - | - | - | - | 508 | 36.573 | 12.253 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 1.048 | 34.801 | 12.884 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -540 | 1.772 | -631 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -540 | 1.544 | -631 |
| Employees | - | - | - | - | - | - | - | 0 | 2 | 1 |
Check the financial reports for the company - Tuvimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 36.517 | 83.671 | 72.840 |
| Current Assets | - | - | - | - | - | - | - | 73.408 | 3.709 | 1.292 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 836 |
| Receivables | - | - | - | - | - | - | - | 24.554 | 0 | 0 |
| Cash | - | - | - | - | - | - | - | 48.854 | 3.709 | 455 |
| Shareholders Funds | - | - | - | - | - | - | - | -500 | 1.045 | 409 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 12.718 | 2.664 | 883 |
| Income in Advance | - | - | - | - | - | - | - | 97.708 | 83.671 | 72.840 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Tuvimed S.r.l.